Sagis Diagnostics

What Sagis Diagnostics does

Sagis Diagnostics (legal entity Sagis, PLLC) is a 100% physician-owned, multispecialty diagnostic pathology laboratory headquartered in Houston, Texas. Founded in 2012 by dermatopathologists, the company operates a CAP-accredited, CLIA-certified laboratory offering diagnostic services across eight subspecialty lines: dermatopathology, podiatric pathology, urologic pathology, gastrointestinal and liver pathology, hematopathology, cytopathology, hospital and surgery center pathology, and toxicology. The technical stack combines immunohistochemistry, fluorescent in-situ hybridization (FISH), molecular diagnostics including PCR-based pathogen and wound panels (Urinsight, GI Pathogen, Fungal & Wound), digital pathology via the Gestalt PathFlow platform with AI-enabled pre-screening, and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) toxicology covering 75+ analytes and 300+ brand-name medications. A team of 35+ board-certified pathologists, many trained at MD Anderson, Columbia, and Mount Sinai, provides subspecialty interpretation with 24–48 hour standard turnaround.

The company serves physicians, specialty practices (dermatology, podiatry, urology, GI, hematology/oncology), community hospitals, and surgery centers nationwide. Revenue is generated on a fee-for-service basis through insurance billing (Medicare, Medicaid, major private insurers) and direct client billing. Go-to-market is sales-led via territory-based local sales representatives, supplemented by direct physician-to-physician communication and a multi-channel marketing approach anchored on educational content (Dermpath CORE Exam Review, Dermpath Happy Hour, Dermpath Educational Library, Podi Derm Board Review) targeting dermatology and podiatry residents. Technology platforms include the SEAM EHR Access Module for embedded ordering and results delivery, Vital Axis for diagnostic reporting, and CareEvolve for toxicology results. Operational scale is indicated by 101–250 total employees, hospital laboratory directorships across multiple Texas-region facilities, and a brand recognized by leading US healthcare systems including Houston Methodist, Memorial Hermann, MD Anderson Cancer Center, and Harris Health System.

Name

Sagis Diagnostics

Legal name

Sagis, PLLC

Website

https://sagisdx.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

Sagis Diagnostics is a 100% physician-owned, multispecialty pathology laboratory in Houston providing dermatopathology, podiatric, urologic, GI, hematopathology, cytopathology, hospital-based, and toxicology diagnostic services to physicians and health systems nationwide.

Ownership category

akta.pro rank

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Pathology Services: Laboratory diagnostic services spanning multiple pathology subspecialties (dermatopathology, podiatric pathology, urologic pathology, GI/hepatobiliary pathology, hematopathology, cytopathology, surgical pathology, and toxicology) provided to physicians, clinics, and health systems on a fee-for-service basis. Revenue is generated through insurance billing (Medicare, Medicaid, and major private insurers) and direct client billing.
2. Toxicology Testing Services: Comprehensive urine and oral fluid toxicology testing using LC-MS/MS technology, detecting over 75 analytes and 300+ brand-name medications. Billed through insurance contracts and direct laboratory billing.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Sagis Diagnostics is a physician-owned multispecialty pathology laboratory providing diagnostic interpretation services across dermatopathology, podiatric pathology, urologic pathology, GI and hepatobiliary pathology, hematopathology, cytopathology, hospital-based pathology, and toxicology. The Houston, TX-based laboratory processes specimens submitted by physicians, clinics, and health systems nationwide, delivering reports with 24-48 hour standard turnaround times through secure portals and EHR-integrated delivery.

Product overview

Sagis Diagnostics is a 100% physician-owned, multispecialty diagnostic pathology laboratory providing comprehensive diagnostic services across multiple service lines. Founded in 2012 and serving physicians nationwide, the company offers a unified portfolio combining core pathology services (dermatopathology, podiatric pathology, GI & liver pathology, hematopathology, urologic pathology, cytopathology, hospital-based pathology, and toxicology) with technology platforms including the SEAM EHR integration system, Vital Axis and CareEvolve reporting portals, and educational products such as the Dermpath CORE Exam Review and Dermpath Educational Library. The company employs over 35 board-certified pathologists and operates from a CAP-accredited and CLIA-certified laboratory in Houston, TX.

Differentiator

Problem solved

Functional benefit

Brands

• SEAM (Sagis EHR Access Module): Automated EHR integration platform that streamlines lab ordering and results delivery directly within a physician's existing electronic health record system.
• Urinsight

Products and services

• Dermatopathology Services Diagnostic pathology interpretation for skin and soft tissue diseases, including complex inflammatory conditions, melanocytic lesions, sarcoma, and cutaneous leukemia/lymphoma, performed by board-certified dermatopathologists for dermatology practices and referring physicians.
• Podiatric Pathology Services

Named customers9 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Gestalt (PathFlow)coreTechnology or Integration · 1 February 2024Sagis partnered with Gestalt Diagnostics for digital pathology integration using their PathFlow platform. This strategic move enables Sagis to streamline diagnostics, boost efficiency, reduce operational costs by eliminating daily courier services, and enable real-time collaboration among pathologists across locations. The integration includes AI algorithms for specimen pre-screening and remote work flexibility.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Emerging players

• PathologyWatch: Digital dermatopathology platform combining AI-enabled workflow with subspecialty reads for dermatology practices. Competes in the same dermatopathology space but via a tech-forward, remote-read delivery model.
• StrataDx: Independent dermatopathology lab offering AI-enabled digital pathology services to dermatology practices. Smaller emerging competitor in Sagis's core dermatopathology service line.

Broad incumbents

• Quest Diagnostics: National full-service reference lab with anatomic and clinical pathology capabilities. Overlaps with Sagis on dermatopathology, toxicology, and routine pathology but operates as a broad, scaled incumbent rather than a specialty-focused player.
• Laboratory Corporation of America (Labcorp): One of the largest clinical and anatomic pathology providers in the U.S., serving physician offices and hospitals. Competes with Sagis on routine and specialty pathology as part of a much broader diagnostic portfolio.

Direct peers

• Aurora Diagnostics: Multispecialty anatomic pathology platform serving hospitals and physicians nationwide with subspecialty expertise. Closely comparable operating model prior to its acquisition by Quest Diagnostics.
• PathGroup: Large physician-led anatomic and clinical pathology practice serving hospitals and physicians across the southeastern U.S. Comparable multispecialty pathology model with subspecialty expertise and direct physician access.
• ProPath: Specialty pathology laboratory offering dermatopathology, GI, hematopathology and urologic pathology with physician subspecialists. Direct competitor across multiple Sagis service lines with comparable physician-led positioning.
• Cockerell Dermatopathology: Physician-led dermatopathology lab founded by a renowned dermatopathologist, serving dermatologists with subspecialty expertise. Closely mirrors Sagis's dermatologist-focused service line and physician-ownership model.
• Inform Diagnostics (formerly Miraca Life Sciences): Specialty anatomic pathology lab offering dermatopathology, GI, urologic, and hematopathology services to physician offices nationwide. Directly comparable multispecialty reference lab competing for the same physician client base.

Regional players

• Dermpath Diagnostics (New England): Independent dermatopathology laboratory providing subspecialty dermatopathology services to the East Coast. Comparable service line focus but with a primarily regional footprint versus Sagis's national reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/c/SagisDx
• Facebookfacebook.com/sagisdiagnostics
• LinkedInlinkedin.com/company/sagisdx
• Instagraminstagram.com/sagisdiagnostics

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sagis Diagnostics